MAZE - Maze Therapeutics Inc Projected Future Earnings

Official company branding of Maze Therapeutics, Inc. (MAZE)

The future profit trajectory of Maze Therapeutics Inc (MAZE) is based on the discovery of drugs for kidney and metabolic diseases through genetics. Growth is constrained by costs associated with the environmental modernization of laboratories and a lack of pricing power due to investment dependency. Investor expectations remain stable on this chart, with the value holding at , allowing for a comparison of the consensus forecast with fundamental indicators.

MAZE - mazetx.com Expected Net Income over the range 07/04/2022 - 11/18/2026

Maze Tx - analytical breakdowns and key metrics (MAZE)

Fundamental company analysis:MAZE, Maze Therapeutics
Finished products of Maze Therapeutics, Inc.

Maze Therapeutics Inc (MAZE) maintains resilience against macroeconomic shocks due to the specific nature of genetic development, where success depends on clinical data rather than market cycles. When analyzing forward financial results, investors assess expected earnings adjusted for one-time factors, which allows for the determination of the business's fundamental value through a balance of market expectations and the company's actual scientific efficiency.

Competitor analysis for Maze Therapeutics Inc

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|SION - Expected Profit|Prime Medicine, Inc. (PRME) - Future Profit|TSHA (Taysha Gene Therapies, Inc.) - Future Profit|QURE - Company Profit Forecast|MGTX (MeiraGTx Holdings plc) - Projected Future Earnings|Future Profit REGENXBIO Inc. (RGNX)|Expected Profit Solid Biosciences (SLDB)|ocugen.com (OCGN) - Projected Net Profit|Projected Future Earnings PACB (PacBio Corp)|Expected Net Income BNTC|DSGN: Future Profit|RCKT - Projected Future Earnings|Expected Net Income 4D Molecular Corp FDMT|Future Profit Lexeo|Expected Profit Korro Bio Inc.|Net Profit Forecast EDIT (Editas Medicine)|Expected Profit Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Expected Net Income|Projected Future Earnings CDXS (Codexis, Inc.)|Company Profit Forecast sangamo.com (SGMO)|nautilus.bio - Projected Future Earnings|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings